magenta 发表于 2025-3-25 06:15:04

http://reply.papertrans.cn/1/82/8162/8162-21.png

Dorsal 发表于 2025-3-25 09:02:59

Submitted on: 29 June 2012.
Revised on: 17 August 2012.
Accepted on: 26 September 2012.

___________________EJVES Vascular Forum---ELSEVIER

暗指 发表于 2025-3-25 14:57:53

Submitted on: 24 March 2002.
Revised on: 19 July 2002.
Accepted on: 06 September 2002.

___________________EJVES Vascular Forum---ELSEVIER

实施生效 发表于 2025-3-25 18:28:10

http://reply.papertrans.cn/1/82/8162/8162-24.png

cardiopulmonary 发表于 2025-3-25 23:00:22

Submitted on: 22 March 2024.
Revised on: 24 June 2024.
Accepted on: 07 July 2024.

___________________EJVES Vascular Forum---ELSEVIER

Outwit 发表于 2025-3-26 03:00:31

Submitted on: 15 February 2022.
Revised on: 18 April 2022.
Accepted on: 10 June 2022.

___________________EJVES Vascular Forum---ELSEVIER

Commonplace 发表于 2025-3-26 06:23:43

http://reply.papertrans.cn/1/82/8162/8162-27.png

Optometrist 发表于 2025-3-26 11:18:13

Submitted on: 11 October 2024.
Revised on: 08 November 2024.
Accepted on: 27 December 2024.

___________________EJVES Vascular Forum---ELSEVIER

Vertical 发表于 2025-3-26 16:38:32

Submitted on: 22 March 2014.
Revised on: 16 May 2014.
Accepted on: 10 July 2014.

___________________EJVES Vascular Forum---ELSEVIER

menopause 发表于 2025-3-26 19:04:37

http://reply.papertrans.cn/1/82/8162/8162-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊EJVES Vascular Forum 2024/2025影响因子:1.452 (EJVES VASC FORUM) (2666-688X). (SURGERY)(外科手术)Emerging Sources Citation